Castelion's $1.05B Series C: Why Carlyle and JPMorgan Are Now Co-Leading Venture Defense Rounds
    Venture Capital

    Castelion's $1.05B Series C: Why Carlyle and JPMorgan Are Now Co-Leading Venture Defense Rounds

    Jeff Barnes, MBA··11 min read
    QuantumLight's $500M Bet: Can an Algorithm Out-Pick Human VCs?
    Venture Capital

    QuantumLight's $500M Bet: Can an Algorithm Out-Pick Human VCs?

    Jeff Barnes, MBA··11 min read
    Kembangan Capital Partners' Reported $725 Million Raise: What It Signals for Asia-Focused LPs
    Venture Capital

    Kembangan Capital Partners' Reported $725 Million Raise: What It Signals for Asia-Focused LPs

    Jeff Barnes, MBA··11 min read
    The “We Have Great Deal Flow” Line Is Losing Power Fast
    Venture Capital

    The “We Have Great Deal Flow” Line Is Losing Power Fast

    Jeff Barnes, MBA··6 min read
    Co-Invest Rights Changed the Math. Your Allocation Story Has to Catch Up
    Venture Capital

    Co-Invest Rights Changed the Math. Your Allocation Story Has to Catch Up

    Jeff Barnes, MBA··9 min read
    How to Turn a Long Fundraising Cycle Into a Trust-Building Advantage
    Venture Capital

    How to Turn a Long Fundraising Cycle Into a Trust-Building Advantage

    Jeff Barnes, MBA··7 min read
    Your Investment Memo Is the Best Marketing Asset You’re Not Using
    Venture Capital

    Your Investment Memo Is the Best Marketing Asset You’re Not Using

    Jeff Barnes, MBA··8 min read
    Stop Selling Access. Start Selling Judgment.
    Venture Capital

    Stop Selling Access. Start Selling Judgment.

    Jeff Barnes, MBA··6 min read
    Every Raise Has a Hidden Bottleneck. Find It Before Investors Do.
    Venture Capital

    Every Raise Has a Hidden Bottleneck. Find It Before Investors Do.

    Jeff Barnes, MBA··8 min read
    The Quiet Tax on Weak Service Providers in a Fund Raise.
    Venture Capital

    The Quiet Tax on Weak Service Providers in a Fund Raise.

    Jeff Barnes, MBA··6 min read
    The Denominator Effect Is Real. But It’s Not Your Best Excuse.
    Venture Capital

    The Denominator Effect Is Real. But It’s Not Your Best Excuse.

    Jeff Barnes, MBA··7 min read
    The 150-LP Myth: Why Bigger Outreach Lists Usually Mean Worse Fundraising.
    Venture Capital

    The 150-LP Myth: Why Bigger Outreach Lists Usually Mean Worse Fundraising.

    Jeff Barnes, MBA··6 min read